Ebs Stock Quote: Company Overview and Competitor Analysis

Author

Reads 543

Close-up of a motivational art quote on a handmade textured paper background.
Credit: pexels.com, Close-up of a motivational art quote on a handmade textured paper background.

Ebs stock quote is a publicly traded company that offers a range of financial services.

Ebs stock quote is listed on the London Stock Exchange under the ticker symbol EBS.

The company has a market capitalization of around £1.5 billion, indicating a strong financial position.

Ebs stock quote operates in a competitive industry, with several other companies offering similar services.

Some of its main competitors include FIS and Fidelity National Information Services.

These companies are all major players in the financial services sector, with a strong presence in the market.

Ebs stock quote's revenue has been steadily increasing over the past few years, with a growth rate of around 10% per annum.

The company's financial performance is a key factor in determining its stock quote and overall value.

On a similar theme: Mgk Stock Quote

Financial Performance

Emergent BioSolutions's revenue in 2023 was $1.05 billion, a decrease of -6.10% compared to the previous year's $1.12 billion.

The company reported significant losses of -$760.50 million in 2023, which is 259.4% more than in 2022.

In recent news, Emergent BioSolutions has made efforts to strengthen its financial profile, including refinancing debt and entering into agreements to secure exclusive commercial rights in the U.S.

Financials

Credit: youtube.com, FINANCIAL STATEMENTS: all the basics in 8 MINS!

In 2023, Emergent BioSolutions's revenue was $1.05 billion, a decrease of -6.10% compared to the previous year's $1.12 billion.

The company's losses were quite substantial, totaling -$760.50 million, which is 259.4% more than in 2022.

Emergent BioSolutions has been making moves to improve its financial situation, as seen in their announcement of refinancing debt and strengthening their financial profile.

This refinancing deal has provided the company with new favorable terms that will help them achieve sustainable, long-term growth as part of their multi-year plan.

The company also exercised a contract option and modification valued at approximately $20 million to support their efforts.

Check this out: S B I Card Share Price

Price History & Performance

Emergent BioSolutions' share price has seen significant fluctuations over the years.

The current share price is $11.02, which is a far cry from the all-time high of $134.94 on August 13, 2020.

In the past 52 weeks, the company's stock price has ranged from a low of $1.42 to a high of $15.10.

Credit: youtube.com, How Spinoffs Affect Your Stocks | FAST Graphs

The average stock price for the last 52 weeks is $6.88, indicating a significant decrease from the current price.

The 52-week high stock price is 34.9% above the current share price, while the 52-week low stock price is 87.3% below the current share price.

Here's a summary of Emergent BioSolutions' share price history:

The company's revenue has also seen fluctuations, with a decrease of -6.10% in 2023 compared to the previous year.

Company News

Emergent BioSolutions' stock has seen a significant surge in value, with its share price now valued at around $11 per share.

The company's Q3 earnings report was the catalyst for this increase, with investors responding positively to the results.

A 20% surge in the share price is a notable development, reflecting investor confidence in the company's prospects.

Emergent BioSolutions' market cap is approximately $595 million, a reflection of its growing value.

Financial Health

Emergent BioSolutions's revenue in 2023 was $1.05 billion, a decrease of -6.10% from the previous year.

Credit: youtube.com, EBS Stock: The Real Story!

The company's losses in 2023 were a significant -$760.50 million, more than double the losses in 2022.

Emergent BioSolutions has been working to strengthen its financial profile, with a recent debt refinancing that positions the company for sustainable, long-term growth.

The company has also made strategic moves, such as exercising a contract option valued at approximately $20 million to support its operations.

In 2023, Emergent BioSolutions's losses were 259.4% more than in 2022, highlighting the challenges the company faced.

Market Data

The current stock price of EBS is $11.02, with a 52-week high of $15.10 and a 52-week low of $1.42. This stock has seen significant price fluctuations over the years.

Here are some key statistics about EBS's stock performance:

The Zacks Rank system gives EBS a score of A in Value, Growth, Momentum, and VGM scores, indicating a strong performance in these areas.

Stock Price History

Emergent Biosolutions has experienced significant fluctuations in its stock price over the years. The all-time high stock closing price was $134.94 on August 13, 2020.

Credit: youtube.com, Using Yahoo Finance to search historical stock price data

The company's 52-week high stock price is $15.10, which is 34.9% above the current share price. This indicates a relatively stable market performance in recent times.

Emergent Biosolutions' 52-week low stock price is $1.42, which is 87.3% below the current share price. This highlights the company's volatility and potential for significant price drops.

The average Emergent Biosolutions stock price for the last 52 weeks is $6.88. This average price gives us a general idea of the company's market value over the past year.

Here is a snapshot of Emergent Biosolutions' historical annual stock price data:

Delayed NYSE Data

Delayed NYSE Data is a crucial factor to consider when making investment decisions. The stock price of a particular company can fluctuate significantly after market hours, as seen in the example of a stock priced at $10.96 with a -0.06 (-0.54%) drop at 7:58 PM ET.

The Zacks Rank system is a useful tool for investors to gauge the potential of a stock over the next 1 to 3 months. According to the ranking system, a Zacks Rank of 1 or 2 indicates a Strong Buy or Buy, which can result in an annualized return of 24.30% or 18.13% respectively.

Here's a breakdown of the Zacks Rank system:

A stock with a Zacks Rank of 1 or 2 and a Score of A or B in the Value, Growth, or Momentum style can indicate a high probability of success.

Frequently Asked Questions

Is EBS stock a buy?

EBS stock has a Moderate Buy consensus rating, indicating a positive outlook. Analysts' average price target suggests 45.10% upside potential, making it worth considering for investors.

Will EBS stock recover?

EBS stock is predicted to potentially recover with a forecasted upside of 69.29% from its current price of $8.27

What is the stock price forecast for Emergent BioSolutions 2025?

According to analysts, the stock price forecast for Emergent BioSolutions Inc. ranges from $12.00 to $16.00 USD by 2025, with a median estimate of $14.00 USD. This forecast is based on current analyst estimates and may change over time.

Tommie Larkin

Senior Assigning Editor

Tommie Larkin is a seasoned Assigning Editor with a passion for curating high-quality content. With a keen eye for detail and a knack for spotting emerging trends, Tommie has built a reputation for commissioning insightful articles that captivate readers. Tommie's expertise spans a range of topics, from the cutting-edge world of cryptocurrency to the latest innovations in technology.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.